Home
University of Bergen
Jian Chen's picture

Jian Chen

Professor
Department of Clinical Science
  • E-mailJian.Chen@uib.no
  • Phone+47 55 97 67 39
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Thawing plateau time indicating the duration of phase transition from ice to water is the strongest predictor for long-term durable pulmonary vein isolation after cryoballoon ablation for atrial fibrillation—Data from the index and repeat procedures. Frontiers in Cardiovascular Medicine.
  • Show author(s) (2023). A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study. European Heart Journal. 2458-2469.
  • Show author(s) (2022). Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study). Europace. 226-233.
  • Show author(s) (2021). The impacts of contact force, power and application time on ablation effect indicated by serial measurements of impedance drop in both conventional and high-power short-duration ablation settings of atrial fibrillation. Journal of interventional cardiac electrophysiology. 333-339.
  • Show author(s) (2021). The Roles of Fractionated Potentials in Non-Macroreentrant Atrial Tachycardias Following Atrial Fibrillation Ablation: Recognition Beyond Three-Dimensional Mapping. Frontiers in Cardiovascular Medicine.
  • Show author(s) (2021). Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms. American Heart Journal. 103-114.
  • Show author(s) (2021). Cryoballoon ablation vs. antiarrhythmic drugs: First-line therapy for patients with paroxysmal atrial fibrillation. Europace. 1033-1041.
  • Show author(s) (2021). Completeness of Linear or Fractionated Electrogram Ablation in Addition to Pulmonary Vein Isolation on Ablation Outcome: A Substudy of the STAR AF II Trial. Circulation: Arrhythmia and Electrophysiology. 897-899.
  • Show author(s) (2020). Effect of Postablation Monitoring Strategy on Long-Term Outcome for Catheter Ablation of Persistent Atrial Fibrillation: A Substudy of the STAR AF II Trial. Circulation: Arrhythmia and Electrophysiology. E008682.
  • Show author(s) (2020). Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study. American Heart Journal. 64-72.
  • Show author(s) (2020). Asymptomatisk ventrikulær preeksitasjon. Hjerteforum. 13.
  • Show author(s) (2020). Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. e2025473.
  • Show author(s) (2019). Dual-loop biatrial concomitant macroreentrant tachycardia in a patient without previous history of surgery or ablation. HeartRhythm Case Reports. 2-5.
  • Show author(s) (2018). Entrapment and retrieval of a diagnostic electrophysiological catheter in the Chiari network. Journal of Arrhythmia. 647-649.
  • Show author(s) (2018). Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 1719-1720.
  • Show author(s) (2017). Left atrial appendage occluder implantation in Europe: Indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey. Europace. 1737-1742.
  • Show author(s) (2017). Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 123-128.
  • Show author(s) (2017). Impact of acute atrial fibrillation termination and prolongation of atrial fibrillation cycle length on the outcome of ablation of persistent atrial fibrillation: A substudy of the STAR AF II trial. Heart Rhythm. 476-483.
  • Show author(s) (2016). The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: Results of the European Heart Rhythm Association survey. Europace. 623-627.
  • Show author(s) (2016). Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association. Europace. 151-155.
  • Show author(s) (2016). Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society. Europace. 1880-1885.
  • Show author(s) (2016). 10-year follow-up after radiofrequency ablation of idiopathic ventricular arrhythmias from right ventricular outflow tract. Indian Pacing and Electrophysiology Journal. 88-91.
  • Show author(s) (2015). Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey. Europace. 1862-1867.
  • Show author(s) (2015). Left atrial appendage closure-indications, techniques, and outcomes: Results of the European Heart Rhythm Association Survey. Europace. 642-646.
  • Show author(s) (2015). Effect of flecainide on the extension and localization of complex fractionated electrogram during atrial fibrillation. Scandinavian Cardiovascular Journal. 168-175.
  • Show author(s) (2015). EHRA research network surveys: 6 years of EP wires activity. Europace. 1733-1738.
  • Show author(s) (2015). Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey. Europace. 314-317.
  • Show author(s) (2015). Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II. Europace. 1727-1732.
  • Show author(s) (2015). Approaches to catheter ablation for persistent atrial fibrillation. New England Journal of Medicine. 812-822.
  • Show author(s) (2014). Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace. 1521-1523.
  • Show author(s) (2014). Use of event recorders and loop recorders in clinical practice: Results of the European Heart Rhythm Association Survey. Europace. 1384-1386.
  • Show author(s) (2014). Personnel, equipment, and facilities for electrophysiological and catheter ablation procedures in Europe: Results of the European Heart Rhythm Association Survey. Europace. 1078-1082.
  • Show author(s) (2014). How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey. Europace. 1852-1856.
  • Show author(s) (2014). Current periprocedural management of ablation for atrial fibrillation in Europe: Results of the European Heart Rhythm Association survey. Europace. 378-381.
  • Show author(s) (2013). Relationship of quality of life With procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF Randomized Trial. Canadian Journal of Cardiology. 1211-1217.
  • Show author(s) (2013). Long-term outcomes of adjunctive complex fractionated electrogram ablation to pulmonary vein isolation as treatment for non-paroxysmal atrial fibrillation. Journal of interventional cardiac electrophysiology. 19-26.
  • Show author(s) (2013). Forskningsveiledning - en av de essensielle faktorene på «veien til doktorgrad». UNIPED. 45-54.
  • Show author(s) (2013). Ablation effect indicated by impedance fall is correlated with contact force level during ablation for atrial fibrillation. Cardiovascular Electrophysiology. 1210-1215.
  • Show author(s) (2012). Ventricular arrhythmias originating from the aortomitral continuity: an uncommon variant of left ventricular outflow tract tachycardia. Europace. 388-395.
  • Show author(s) (2012). Substrate and trigger ablation for aeduction of atrial fibrillation trial-part II (STAR AF II): design and rationale. American Heart Journal. 1-6.
  • Show author(s) (2012). N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation. Journal of interventional cardiac electrophysiology. 129-136.
  • Show author(s) (2012). Incidence and Significance of Early Recurrences Associated with Different Ablation Strategies for AF: A STAR-AF Substudy. Cardiovascular Electrophysiology. 1295-1301.
  • Show author(s) (2011). Remote magnetic versus manual catheters: evaluation of ablation effect in atrial fibrillation by myocardial marker levels. Journal of interventional cardiac electrophysiology. 37-43.
  • Show author(s) (2010). TEE time? ICETEE time! IntraCardiac Echocardiography probe used for TransoEsophageal Echocardiography. Europace. 1787-1788.
  • Show author(s) (2010). Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial(dagger). European Heart Journal. 1344-1356.
  • Show author(s) (2010). Characteristics and distribution of complex fractionated atrial electrograms in patients with paroxysmal and persistent atrial fibrillation. Journal of interventional cardiac electrophysiology. 87-93.
  • Show author(s) (2009). Spatial relationships between the pulmonary veins and sites of complex fractionated atrial electrograms during atrial fibrillation. Pacing and Clinical Electrophysiology. S190-S193.
  • Show author(s) (2009). Electroanatomical mapping and radiofrequency catheter ablation of atrial tachycardia originating from the donor heart after orthotopic heart transplantation in a child. Journal of interventional cardiac electrophysiology. 73-77.
  • Show author(s) (2009). Atrio-pulmonary vein conduction delay during pulmonary vein isolation for atrial fibrillation is related to vein anatomy, age, and focal activity. Pacing and Clinical Electrophysiology. S207-S210.
  • Show author(s) (2009). Ablasjonsbehandling av takyarytmier hos barn og unge. Tidsskrift for Den norske legeforening. 291-295.
  • Show author(s) (2008). Treatment of atrial fibrillation by silencing electrical activity in the posterior inter-pulmonary-vein atrium. Europace. 265-272.
  • Show author(s) (2007). Significance of late recurrence of atrial fibrillation during long-term follow-up after pulmonary vein isolation. Pacing and Clinical Electrophysiology. S108-S111.
  • Show author(s) (2005). A clinical study of patients with and without recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation. Pacing and Clinical Electrophysiology. S86-S89.
  • Show author(s) (2004). Kurativ behandling av paroksysmal atrieflimmer med radiofrekvensablasjon. Tidsskrift for Den norske legeforening. 625-628.
  • Show author(s) (2000). Real-time monitoring of acute conduction resumption in the cavotricuspid isthmus after common atrial flutter ablation. European Heart Journal. 445.
  • Show author(s) (2000). Initial study of dispersion of the atrial refractory periods in the normal human heart. Europace, Supplements. D 232.
  • Show author(s) (2000). Focal atrial tachycardia may interfere with the diagnosis and follow-up of ablation for atrial flutter: An analysis in patients with clinically documented atrial flutter. Europace, Supplements. D69.
  • Show author(s) (2000). Electrophysiological features of incomplete block in the isthmus during ablation for common atrial flutter. Europace, Supplements. D140.
  • Show author(s) (2000). Assessment of conduction and bidrectional block in the cavotricuspid isthmus during catheter ablation in patients with common atrial flutter. Hjerteforum. 11.
  • Show author(s) (2000). Acute resumption of conduction in the cavotricuspid isthmus after catheter ablation in patients with common atrial flutter. Europace, Supplements. D256.
Masters thesis
  • Show author(s) (2006). Application of different three-dimensional imaging systems for treatment of cardiac arrhythmias.
Letter to the editor
  • Show author(s) (2021). Incidence of Concurrent Atrial Fibrillation in Patients Who Present with Atrial Tachycardia and Atrial Flutter Postablation for Persistent Atrial Fibrillation: Insights from the STAR AF II Trial. Circulation: Arrhythmia and Electrophysiology. 365-366.
  • Show author(s) (2015). Management of paediatric arrhythmias in Europe: Authors' reply. Europace. 1884-1885.
Doctoral dissertation
  • Show author(s) (2004). Radiofrequency catheter ablation of atrial flutter: Clinical results and studies of mechanisms using conventional and noncontact mapping techniques.
Abstract
  • Show author(s) (2009). There is a relation between self-reported arrhythmia burden, atrial size and pro-brain natriuretic peptide in atrial fibrillation patients. Cardiology. 71-71.
  • Show author(s) (2009). Biochemical marker levels after ablation for atrial fibrillation: difference between remote magnetic and conventional irrigated catheter. Cardiology. 70-70.
Poster
  • Show author(s) (2014). The Role of Research Supervision on Doctoral Degree.
  • Show author(s) (2006). Long term clinical outcome of patients receiving an implantable atrial antitachycardia pacing device.
Academic literature review
  • Show author(s) (2018). Patients' knowledge and attitudes regarding living with implantable electronic devices: Results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association. Europace. 386-391.
  • Show author(s) (2017). Cryoablation for treatment of cardiac arrhythmias: Results of the European Heart RhythmAssociation survey. Europace. 303-307.
  • Show author(s) (2016). Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: The European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI). Europace. 778-784.
  • Show author(s) (2016). Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: Result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace. 463-467.
  • Show author(s) (2015). Use of fluoroscopy in clinical electrophysiology in Europe: Results of the European Heart Rhythm Association Survey. Europace. 1149-1152.
  • Show author(s) (2015). Radiofrekvenskateterablasjon hos pasienter med ikke-paroksysmal atrieflimmer? Hjerteforum. 45-46.
  • Show author(s) (2015). Management of patients with ventricular tachycardia in Europe: Results of the European Heart Rhythm Association survey. Europace. 1294-1299.
  • Show author(s) (2010). Magnetstyrt ablasjonsbehandling av hjerterytmeforstyrrelser :. Tidsskrift for Den norske legeforening. 1467-1470.

More information in national current research information system (CRIStin)